Volume 32, Issue 2, Pages (February 2000)

Slides:

Advertisements

Similar presentations

A Role for Dystroglycan in Basement Membrane Assembly Michael D Henry, Kevin P Campbell Cell Volume 95, Issue 6, Pages (December 1998) DOI: /S (00)

Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Volume 63, Issue 1, Pages (July 2015)

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

Volume 41, Issue 6, Pages (December 2004)

The impact of hepatitis E in the liver transplant setting

Clinical Factors Associated With Liver Stiffness in Hepatitis B e Antigen–Positive Chronic Hepatitis B Patients Grace Lai–Hung Wong, Vincent Wai–Sun.

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Alan Hoofring, John Boitnott, Michael Torbenson Journal of Hepatology

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis Wichit Srikureja,

Volume 39, Issue 3, Pages (September 2003)

Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”

The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting Adnan Said, John Williams, Jeremy Holden,

Susanna L. Matsen, MD, Bruce A. Perler, MD, MBA, David C

Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

The impact of hepatitis E in the liver transplant setting

Fibrogenic impact of high serum glucose in chro nic hepatitis C

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting Adnan Said, John Williams, Jeremy Holden,

Virological tools to diagnose and monitor hepatitis C virus infection

Natural history of hepatitis B

Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results Bruno Roche, Didier Samuel Journal.

Living donor liver transplantation: is the hype over?

Clinical Factors Associated With Liver Stiffness in Hepatitis B e Antigen–Positive Chronic Hepatitis B Patients Grace Lai–Hung Wong, Vincent Wai–Sun.

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.

Chronic HCV infection and the clonality of intrahepatic T cells

F. Li, P. Zhou, W. Deng, J. Wang, R. Mao, Y. Zhang, J. Li, J. Yu, F

Volume 68, Issue 1, Pages (January 2018)

Assessment of FIBROSpect II to Detect Hepatic Fibrosis in Chronic Hepatitis C Patients Atif Zaman, MD, MPH, Hugo R. Rosen, MD, Ken Ingram, PA-C, Christopher.

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Diagnostic Value of Quantitative Hepatic Copper Determination in Patients With Wilson’s Disease Peter Ferenci, Petra Steindl-Munda, Wolfgang Vogel, Wolfgang.

Effect of Interferon-Gamma on Hepatic Fibrosis in Chronic Hepatitis B Virus Infection: A Randomized Controlled Study Hong-Lei Weng, Bao-En Wang, Ji-Dong.

From non-A, non-B hepatitis to hepatitis C virus cure

Volume 70, Issue 1, Pages (January 2019)

Aloysious D. Aravinthan, Graeme J.M. Alexander Journal of Hepatology

Trends in the management and burden of alcoholic liver disease

Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease

Cirrhosis and other liver disease in cystic fibrosis

Volume 62, Issue 3, Pages (March 2015)

John Widger, Sarath Ranganathan, Philip J. Robinson

Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C Evangelista Sagnelli, Mariantonietta.

Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Obese or Overweight Patients Sven M.A. Francque, An Verrijken, Ilse Mertens, Guy Hubens,

Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients O.O. Ogunkeye, E.K. Chuhwak, A.A.E. Otokwula

EASL Clinical Practice Guidelines: Wilson’s disease

Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg

Economics of chronic hepatitis B and hepatitis C

Volume 70, Issue 1, Pages (January 2019)

Volume 53, Issue 2, Pages (August 2010)

Volume 65, Issue 2, Pages (August 2016)

Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis.

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease Sylvie Naveau, Bruno Raynard, Vlad Ratziu, Annie Abella,

Correlation of FIBROSpect II With Histologic and Morphometric Evaluation of Liver Fibrosis in Chronic Hepatitis C Keyur Patel, David R. Nelson, Don C.

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Susan Vickery, PhD, Edmund J. Lamb, PhD, R. Ian John, MBBChir, Nasir A

Volume 50, Issue 3, Pages (March 2009)

Volume 64, Issue 6, Pages (June 2016)

Volume 17, Issue 2, Pages (February 1950)

Volume 63, Issue 1, Pages (July 2015)

Volume 142, Issue 6, Pages e4 (May 2012)

Pathogenesis of cholestatic hepatitis C

Volume 1, Issue 1, Pages 2-8 (May 2019)

Chimeric mouse model of hepatitis B virus infection

Raymond D’Souza, Michael J

Volume 44, Issue 2, Pages (February 2006)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Presentation transcript:

Volume 32, Issue 2, Pages 325-330 (February 2000) Basement membrane peptides as markers of liver disease in chronic hepatitis C Kevin Michael Walsh, Alexander Fletcher, Roderick N.M MacSween, Allan John Morris Journal of Hepatology Volume 32, Issue 2, Pages 325-330 (February 2000) DOI: 10.1016/S0168-8278(00)80079-3

Fig. 1 a. Stage of fibrosis in patients with chronic hepatitis C. b. Scatter plot of serum type IV collagen vs stage of fibrosis in chronic hepatitis C. c. Scatterplot of serum laminin vs stage of fibrosis in chronic hepatitis C. Journal of Hepatology 2000 32, 325-330DOI: (10.1016/S0168-8278(00)80079-3)

Fig. 2 a. Histological activity index - a summary score of necroinflammation - in patients with chronic hepatitis C. b. Scatterplot of serum type IV collagen vs histological activity index in chronic hepatitis C. c. Scatterplot of serum laminin vs histological activity index in chronic hepatitis C. Journal of Hepatology 2000 32, 325-330DOI: (10.1016/S0168-8278(00)80079-3)

Fig. 3 ROC curve comparing ability of serum type IV collagen, laminin and ALT to detect advanced liver injury in chronic hepatitis C. Journal of Hepatology 2000 32, 325-330DOI: (10.1016/S0168-8278(00)80079-3)